14-3-3 σ and checkpoint with forkhead and ring finger (CHFR) methylation in serum in erlotinib-treated non-small-cell lung cancer (NSCLC) patients (p) with EGFR mutations

被引：0
|
作者：
Reguart, N.
Porta, R.
Provencio, M.
Cardenal, F.
Cuello, M.
Ramirez, J. L.
Mayo, C.
Lianes, P.
Taron, M.
Rosell, R.
机构：
[1] Hosp Badalona Germans Trias & Pujol, ICO, Badalona, Spain
[2] Hosp Josep Trueta, ICO, Girona, Spain
[3] Clin Puerta del Hierro, Madrid, Spain
[4] Hosp Duran & Reynals, ICO, Barcelona, Spain
[5] Hosp Mataro, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7600
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Mitotic checkpoint gene CHFR methylation in pretreatment serum DNA of docetaxel (doc)/cisplatin (cis)-treated stage IV non-small cell lung cancer (NSCLC) patients (p).
    Isla, D.
    Salazar, F.
    Ramirez, J.
    Ronco, M. Sanchez
    Cobo, M.
    Montes, A.
    Sanchez, J.
    Catot, S.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 378S - 378S
  • [32] Methylation of 14-3-3σ gene and prognostic significance of 14-3-3σ expression in non-small cell lung cancer
    Raungrut, Pritsana
    Petjaroen, Pingpond
    Geater, Sarayut Lucien
    Keeratichananont, Warangkana
    Phukaoloun, Monlika
    Suwiwat, Supaporn
    Thongsuksai, Paramee
    ONCOLOGY LETTERS, 2017, 14 (05) : 5257 - 5264
  • [33] Serum EGFR in patients with non-small cell lung cancer (NSCLC) treated with gefitinib
    Spreafico, A
    Gregorc, V
    Ludovini, V
    Pistola, L
    Amoroso, M
    Tofanetti, F
    Compagnoni, A
    Aondio, G
    Tonato, M
    Villa, E
    LUNG CANCER, 2005, 49 : S112 - S113
  • [34] Multicenter prospective study of erlotinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations
    Cardenal, Felipe
    Moran, Teresa
    Queralt, Cristina
    Porta, Ruth
    Camps, Carlos
    Majem, Margarita
    Lopez-Vivanco, Guillermo
    Isla, Dolores
    Provencio, Mariano
    Sanchez, Jose Javier
    Taron, Miquel
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S324 - S325
  • [35] EVEROLIMUS PLUS ERLOTINIB VERSUS ERLOTINIB ALONE IN PREVIOUSLY TREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Bennouna, J.
    Besse, B.
    Leighl, N. B.
    Blais, N.
    Traynor, A. M.
    Papadimitrakopoulou, V.
    Klimovsky, J.
    Jappe, A.
    Jehl, V.
    Johnson, B. E.
    ANNALS OF ONCOLOGY, 2010, 21 : 140 - 140
  • [36] A cost utility analysis of erlotinib in patients with previously treated advanced non-small-cell lung cancer (NSCLC)
    Bradbury, P. A.
    Jang, R.
    Isogai, P.
    Mittmann, N.
    Evans, W.
    Shepherd, F. A.
    Leighl, N. B.
    Ng, R.
    VALUE IN HEALTH, 2008, 11 (03) : A72 - A72
  • [37] BRCA1 and Astrocyte Elevated Gene-1 (AEG-1) Expression and Outcome of Erlotinib-Treated Non-Small-Cell Lung Cancer (NSCLC) Patients (p) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
    Taron, M.
    Benlloch, S. B.
    Sanchez, J. J. S.
    Rosell, R. R.
    Costa, C. C.
    Queralt, C. Q.
    Mayo, C. M.
    de Aguirre, I. A.
    Moran, T. M.
    Massuti, B. M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S593 - S593
  • [38] BIM EXPRESSION AND POLYMORPHISMS IN EGFR-MUTANT NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (PTS) TREATED WITH ERLOTINIB IN COLOMBIA (CLICAP)
    Cardona Cardona, Andres Felipe
    Arrieta, Oscar
    Karachaliou, Niki
    Drozdowskyj, Ana
    Gimenez Capitan, Ana
    Angel Molina, Miguel
    Carranza, Hernan
    Vargas, Carlos
    Otero, Jorge
    Rojas, Leonardo
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S198 - S199
  • [39] High mRNA expression of LMO4, a BRCA1 downregulator, correlates with better prognosis in erlotinib-treated non-small cell lung cancer (NSCLC) patients (p) with EGFR mutations.
    Viteri Ramirez, Santiago
    Costa, Carlota
    Gimenez Capitan, Ana
    Benlloch, Susana
    Taron, Miquel
    Javier Sanchez, Jose
    Gasco, Amaya
    Martinez-Bueno, Alejandro
    Karachaliou, Niki
    Camps, Carlos
    Moran, Teresa
    Carcereny Costa, Enric
    Massuti, Bartomeu
    Cardenal, Felipe
    Porta, Rut
    Bosch, Joaquim
    Palmero, Ramon
    Buges, Cristina
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] C-erbB-3 Expression in Non-small Cell Lung Cancer (NSCLC) Patients Treated by Erlotinib
    Cstoth, Ingrid
    Anthoine, Geraldine
    Berghmans, Thierry
    Mascaux, Celine
    Paesmans, Marianne
    Sculier, Jean-Paul
    Meert, Anne-Pascale
    ANTICANCER RESEARCH, 2011, 31 (01) : 281 - 285
12345